Edwards Lifesciences

Open: 90.02 Close: 90.26 Change: 0.24

Don't invest before reading what an AI found about Edwards Lifesciences Company Inc Stock.

The game is changing. There is a new strategy to evaluate Edwards Lifesciences fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Edwards Lifesciences are: Edwards, Lifesciences, stock, Corp, EW, price, year, …

Concept Map

Semantic Network

Stock Summary

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, critical care and surgical monitoring. It offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name. The company distributes.

Today's Summary

Edwards Lifesciences Corp (EW) stock is trading at $92.56 as of 9:57 AM on Monday, Jul 3, a loss of -$1.77, or -1.88% from the previous closing price of $94.33. The company had US$596.5m in debt in March 2023; about the same as the year before.

Today's News

Edwards Lifesciences Corp (EW) stock is trading at $92.56 as of 9:57 AM on Monday, Jul 3, a loss of -$1.77, or -1.88% from the previous closing price of $94.33. The company had US$596.5m in debt in March 2023; about the same as the year before. The majority of liabilities falling back on past tenancies accept ethical ways CPCv Maher Haramedes Edwards Lifesciences stock has experienced highs and lows over the past year but has shown impressive resilience throughout various market conditions. CVP, CFO Scott Ullem Sells 7255 Shares of Edwards Lifsciences Corp (EW) Insider Sell: CVP and CFO sells 7255 shares. Edwards Lifesciences currently holds a consensus rating of “Hold” among analysts covering the stock. Barclays raised their target price from $94.00 to $102.00 in another research note. Headquartered in Irvine, California, Edwards has extensive operations in North America. Edwards Lifesciences is the global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring. This is a unique opportunity to join an early-stage product development group.

Stock Profile

"Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California."

Keywords

How much time have you spent trying to decide whether investing in Edwards Lifesciences? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Edwards Lifesciences are: Edwards, Lifesciences, stock, Corp, EW, price, year, and the most common words in the summary are: edward, lifesciences, stock, market, price, medical, report, . One of the sentences in the summary was: The company had US$596.5m in debt in March 2023; about the same as the year before.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #edward #lifesciences #stock #market #price #medical #report.